Cheng‐Liang Peng
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery 20
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics 23
- Pharmaceutical Science top 5%
- Molecular Medicine top 5%
-
- Photodynamic Therapy Research Studies 11
-
- Cancer Immunotherapy and Biomarkers 8
-
- Radiopharmaceutical Chemistry and Applications 6
-
- Hepatocellular Carcinoma Treatment and Prognosis 6
-
- Immune Cell Function and Interaction 6
- Immunotherapy and Immune Responses 5
- Co-authors
- Ming‐Jium ShiehPing‐Shan LaiTsai‐Yueh LuoYing‐Hsia ShihPei‐Chi LeePei‐Jen LouFeng‐Huei LinTai‐Horng Young
- Partner nations
- TaiwanUnited StatesUnited Kingdom
In The Last Decade
Cheng‐Liang Peng
59 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 101
- Biomaterials 806
- Biomedical Engineering 1000
- Pharmaceutical Science 123
- Molecular Medicine 94
- Pulmonary and Respiratory Medicine 465
Countries citing papers authored by Cheng‐Liang Peng
This map shows the geographic impact of Cheng‐Liang Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Liang Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Liang Peng more than expected).
Fields of papers citing papers by Cheng‐Liang Peng
This network shows the impact of papers produced by Cheng‐Liang Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Liang Peng. The network helps show where Cheng‐Liang Peng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cheng‐Liang Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 10 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 13 | |
| 6 | 2022 | 22 | |
| 7 | 2022 | 3 | |
| 8 | 2021 | 4 | |
| 9 | 2020 | 12 | |
| 10 | 2020 | 11 | |
| 11 | 2018 | 36 | |
| 12 | 2017 | 21 | |
| 13 | 2016 | 18 | |
| 14 | 2014 | 5 | |
| 15 | 2011 | 8 | |
| 16 | 2009 | 128 | |
| 17 | 2008 | 111 | |
| 18 | 2008 | 85 | |
| 19 | 2007 | 32 | |
| 20 | 1973 | 4 |
About Cheng‐Liang Peng
Cheng‐Liang Peng is a scholar working on Biomaterials, Hepatology and Oncology, having authored 61 papers that have together received 2.1k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (23 papers), Nanoparticle-Based Drug Delivery (20 papers), Photodynamic Therapy Research Studies (11 papers), Cancer Immunotherapy and Biomarkers (8 papers), Radiopharmaceutical Chemistry and Applications (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Immune Cell Function and Interaction (6 papers) and Immunotherapy and Immune Responses (5 papers). The work is most often cited by research in Biomaterials (806 citations), Biomedical Engineering (1000 citations) and Pharmaceutical Science (123 citations). Cheng‐Liang Peng has collaborated with scholars based in Taiwan, United States and United Kingdom. Frequent co-authors include Ming‐Jium Shieh, Ping‐Shan Lai, Tsai‐Yueh Luo, Ying‐Hsia Shih, Pei‐Chi Lee, Pei‐Jen Lou, Feng‐Huei Lin, Tai‐Horng Young, Ming‐Hsien Tsai and Shu‐Jyuan Yang. Their work appears in journals such as ACS Nano, Biomaterials and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.